Sign in
4

Changes in Ownership

Design Therapeutics, Inc. Filed Acc 0001209191-23-033784

Options or other derivatives

  • Director acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Schmid John P. Director 2023-05-31 Grant or award · Stock Option (right to buy) +15,000 15,000 D
Loading xslF345X04/doc4.xml…